New England Journal of Medicine · 2017 · 926 citations · 27 references
Coronary revascularization guided by iFR was noninferior to revascularization guided by FFR with respect to the risk of major adverse cardiac events at 1 year. The rate of adverse procedural signs and symptoms was lower and the procedural time was shorter with iFR than with FFR. (Funded by Philips Volcano; DEFINE-FLAIR ClinicalTrials.gov number, NCT02053038 .).
27
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.3K citations · Full text
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.8K citations · Full text
2014 ESC/EACTS Guidelines on myocardial revascularization
European Heart Journal · 2014 · 4.3K citations · Full text
Friedrich W. Mohr, Marie-Claude Morice, A. Pieter Kappetein et al. · The Lancet · 2013 · 1.8K citations
Cardiac Surgery, Percutaneous Coronary Intervention, Endovascular Technique +8